A method of treating HBV or HIV infections comprising administering to an individual
an effective amount of the compound of formula IId:
##STR1##
- wherein R2 is the residue of an aliphatic L-amino acid, p
is 0, 1, or 2-20, and q is 0, or a pharmaceutically acceptable salt thereof.
|
|
|